C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2757717
The present invention describes an association between genetic polymorphisms in the FAM13A1 (family with sequence similarity 13, member Al) gene and a predisposition to prolongation of the QT interval, and provides related methods for the prediction of such a predisposition, the administration of QT interval- prolonging compounds to individuals having such a predisposition, and determining whether a compound is capable of inducing QT prolongation.
La présente invention décrit une association entre des polymorphismes génétiques dans le gène FAM13A1 (famille à similarité de séquence 13, membre A1) et une prédisposition à la prolongation de l'intervalle QT, et porte sur des procédés apparentés pour la prédiction d'une telle prédisposition, l'administration de composés prolongeant l'intervalle QT à des individus ayant une telle prédisposition, et la détermination du fait qu'un composé est capable ou non d'induire une prolongation de QT.
Lavedan Christian
Licamele Louis
Volpi Simona
Shapiro Cohen
Vanda Pharmaceuticals Inc.
LandOfFree
Method of predicting a predisposition to qt prolongation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of predicting a predisposition to qt prolongation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of predicting a predisposition to qt prolongation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1523731